KINNATE BIOPHARMA INC

CUSIP: 49705R105 Class: Common Stock

RHUMBLINE ADVISERS's Holding History (CIK: 0001115418)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 2,933 Value ($000) $8 Avg Close — Range —
Q4 2023
Shares 2,933 Value ($000) $7 Avg Close — Range —
Q3 2023
Shares 2,933 Value ($000) $4 Avg Close — Range —
Q2 2023
Shares 4,600 Value ($000) $14 Avg Close — Range —
Q1 2023
Shares 52,373 Value ($000) $0 Avg Close — Range —
Q4 2022
Shares 46,045 Value ($000) $0 Avg Close — Range —
Q3 2022
Shares 45,773 Value ($000) $547 Avg Close — Range —
Q2 2022
Shares 42,957 Value ($000) $542 Avg Close — Range —
Q1 2022
Shares 32,079 Value ($000) $361 Avg Close — Range —
Q4 2021
Shares 30,270 Value ($000) $536 Avg Close — Range —
Q3 2021
Shares 29,972 Value ($000) $690 Avg Close — Range —
Q2 2021
Shares 15,455 Value ($000) $360 Avg Close — Range —
Q1 2021
Shares 11,697 Value ($000) $364 Avg Close — Range —